HCA Healthcare, Inc. $HCA Shares Sold by Metropolis Capital Ltd

Metropolis Capital Ltd reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 882,944 shares of the company’s stock after selling 27,620 shares during the quarter. HCA Healthcare makes up about 10.4% of Metropolis Capital Ltd’s holdings, making the stock its 2nd largest position. Metropolis Capital Ltd’s holdings in HCA Healthcare were worth $376,788,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. Norway Savings Bank grew its stake in shares of HCA Healthcare by 4.9% during the 3rd quarter. Norway Savings Bank now owns 5,064 shares of the company’s stock worth $2,161,000 after acquiring an additional 235 shares during the period. Net Worth Advisory Group increased its holdings in HCA Healthcare by 51.1% in the 3rd quarter. Net Worth Advisory Group now owns 2,239 shares of the company’s stock worth $948,000 after acquiring an additional 757 shares during the last quarter. CWA Asset Management Group LLC raised its stake in HCA Healthcare by 7.6% in the 3rd quarter. CWA Asset Management Group LLC now owns 930 shares of the company’s stock valued at $397,000 after acquiring an additional 66 shares during the period. Frank Rimerman Advisors LLC lifted its holdings in HCA Healthcare by 0.9% during the third quarter. Frank Rimerman Advisors LLC now owns 6,677 shares of the company’s stock valued at $2,849,000 after purchasing an additional 60 shares during the last quarter. Finally, AlphaStar Capital Management LLC boosted its position in HCA Healthcare by 11.9% during the third quarter. AlphaStar Capital Management LLC now owns 4,162 shares of the company’s stock worth $1,776,000 after purchasing an additional 441 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA was highlighted as a strong momentum stock by Zacks, suggesting favorable recent price and trading trends may continue to attract momentum-oriented investors. Here’s Why HCA Healthcare Is a Strong Momentum Stock
• Positive Sentiment: Zacks also identified HCA as a top long-term stock based on its earnings outlook and potential to outperform, reinforcing the longer-term bullish case. Why HCA Healthcare Is a Top Stock for the Long-Term
• Positive Sentiment: HCA’s TriStar Centennial plans to invest $90 million in women’s and children’s services, a move that could strengthen its regional healthcare franchise and support future capacity and revenue growth. HCA’s TriStar Centennial to Invest $90 Million
• Neutral Sentiment: Twenty-four analysts reportedly have a consensus target of $467.61, indicating limited additional upside relative to the current trading level and no major change in Wall Street sentiment. HCA Healthcare Analyst Consensus Target
• Neutral Sentiment: The HCA Healthcare Foundation awarded $25,000 to a Virginia youth mental-wellness program. The announcement supports community relations but is unlikely to materially affect near-term financial results. HCA Healthcare Foundation Award
• Negative Sentiment: Zacks expects HCA to report a year-over-year earnings decline and says the company lacks the key factors that typically support an earnings beat. This is the most important near-term risk ahead of Tuesday’s report and could pressure the stock if results or guidance disappoint. Analysts Estimate HCA Healthcare to Report a Decline in Earnings

HCA Healthcare Stock Performance

NYSE HCA traded up $8.73 during trading hours on Tuesday, hitting $463.61. The company had a trading volume of 597,550 shares, compared to its average volume of 1,335,850. The firm has a market capitalization of $100.37 billion, a price-to-earnings ratio of 15.53, a PEG ratio of 1.55 and a beta of 1.10. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The firm has a 50 day simple moving average of $427.22 and a 200 day simple moving average of $418.81.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the business posted $6.84 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. On average, research analysts forecast that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.45%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Oppenheimer reduced their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research note on Monday, July 27th. Royal Bank Of Canada upped their price target on shares of HCA Healthcare from $435.00 to $496.00 and gave the company an “outperform” rating in a research note on Wednesday, October 7th. BMO Capital Markets started coverage on shares of HCA Healthcare in a report on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 price objective for the company. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 7th. Finally, TD Cowen boosted their target price on shares of HCA Healthcare from $431.00 to $460.00 and gave the company a “buy” rating in a report on Monday, October 12th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $467.61.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.